CAYLA DANIELE: Open Payments
NPI 1770025132 · DERBY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 106 payments from 10 companies in 2025. Trend: 2023 $1,257 · 2024 $1,816 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 79 | $1,188 |
| Sage Therapeutics, LLC | 7 | $136 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $96 |
| ABBVIE INC. | 3 | $70 |
| Exact Sciences Corporation | 2 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| CooperSurgical, Inc. | 2 | $39 |
| Organon LLC | 2 | $39 |
| MILLICENT US INC | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: SLYND, TYBLUME, ZURZUVAE, NUVESSA, Qelbree, QULIPTA, Paragard T 380A, NEXPLANON.
Industry payments across CT — which companies pay providers there.
